← Leaderboards
Ching Ching Lau
Baylor College Of Medicine
$5,029,277
Attributed
$5,851,458
Total exposure
5
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $649K · FY2005–20$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$5,851,458 · 5
By mechanism
U01$2,140,997 · 1
R33$2,118,569 · 1
R01$1,233,272 · 1
P30$198,945 · 1
R21$159,675 · 1
Top collaborators
- Graham Casey2 shared
- Rose Kamyee Lai2 shared
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Jianming Xu$13,357,961
Others in their field
Top investigators on “Neoplasm /Cancer Genetics”
- Gregory H Reaman · National Childhood Cancer Foundation$112,559,481
- Charles A Coltman · Southwest Oncology Group$46,831,444
- Samuel A Wells · Duke University$32,148,803
- David Sidransky · Johns Hopkins University$27,906,864
- Brian E Henderson · University Of Southern California$27,493,155
- Bruce W Stillman · Cold Spring Harbor Laboratory$22,532,365
Research focus
Neoplasm /Cancer GeneticsGene ExpressionNeoplasm /Cancer Classification /StagingPediatric Neoplasm /CancerPolymerase Chain ReactionClinical ResearchHuman SubjectOutcomes ResearchMicroarray TechnologyCooperative StudyOsteosarcomaGenetic MarkersComplementary DnaMolecular OncologyBiopsyIn Situ HybridizationImmunocytochemistryMessenger RnaMetastasisEpendymomaComparative Genomic HybridizationGliaBaseGrowth Factor
Grant awards (13)
Functional Characterization of Glioma GWAS Variants$584,230
R01 · FY2020 · CA
Functional Characterization of Glioma GWAS Variants$649,042
R01 · FY2018 · CA
Genomic Profile-Based Prognostic Markers for Ependymoma$528,774
R33 · FY2007 · CA · contact PI
Genomic Profile-Based Prognostic Markers for Ependymoma$530,713
R33 · FY2006 · CA · contact PI
Genomic Profile-Based Prognostic Markers for Ependymoma$529,673
R33 · FY2005 · CA
Genomic Profile-Based Prognostic Markers for Ependymoma$529,409
R33 · FY2004 · CA
MOLECULAR CLASSIFICATION OF OSTEOSARCOMA$488,445
U01 · FY2004 · CA
MOLECULAR CLASSIFICATION OF OSTEOSARCOMA$586,795
U01 · FY2003 · CA
MOLECULAR CLASSIFICATION OF OSTEOSARCOMA$494,235
U01 · FY2002 · CA
Genomic Profile-Based Prognostic Markers for Ependymoma$159,675
R21 · FY2002 · CA
MOLECULAR CLASSIFICATION OF OSTEOSARCOMA$571,522
U01 · FY2001 · CA
MOLECULAR BIOLOGY OF MEDULLOBLASTOMA$131,864
P30 · FY2001 · HD
MOLECULAR BIOLOGY OF MEDULLOBLASTOMA$67,081
P30 · FY2000 · HD